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Mouse neoplasms induced by adenovirus type  12  contain common specific 
antigens detectable by the isograft rejection technique and are thereby similar 
to  other viral  tumors  (1,  2,  3).  Transplantation  resistance  against grafted 
tumor cells has been obtained either by pretreating mice with adeno 12 tumor 
cells or by infecting them with the adeno 12 virus (4, 3). Infection  of the animals 
with adenovirus type 7 has also been found to produce immunity against trans- 
planted adeno 12 tumors while infection with adenovirus type 5 has not (4). The 
adenovirus tumor  system is in  this  respect different from other viral tumor 
systems in which the transplantation resistance induced by virus infection is 
limited to tumors induced by the infecting virus (2). 
Specific,  new  antigens  (neoantigens)  of  adeno  12  tumors  have  also  been 
demonstrated  with  complement fixation  (CF)  and  immunofluorescence tech- 
niques (6, 7). These antigens have been reported as having an exclusively intra- 
cellular localization (7, 8) and are, therefore, probably distinct from the trans- 
plantation antigens which are considered to be represented on the cell surface 
(9, 10). It appears to be of importance to clarify the possible relationships be- 
tween the neoantigens and the transplantation antigen in adenovirus tumors. 
Furthermore the existence of a  series of antigenically well characterized onco- 
genie  and  nononcogenie adenoviruses makes  adeno  tumors  ideal  for further 
research on the role of tumor-specific antigens in viral oncogenesis. As a  first 
attempt in our approach to these problems we have applied an in vitro tech- 
nique for the demonstration of the transplantation antigen of adeno tumor cells. 
The colony inhibition (CI) test was chosen, because it had been previously used 
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successfully  for  the  demonstration  of  the  polyoma-specific  transplantation 
antigens (11,  12).  This test is also capable of detecting cell-bound immunity 
reactions against tumor-specific antigens (13). The present paper describes the 
demonstration of specific humoral and cell-bound immunity against the trans- 
plantation antigens of  adenovirus 12-induced tumors.  It also  shows a  cross- 
reaction between the transplantation antigens of mouse and hamster adeno 12 
tumors, similar to that previously reported in the polyoma system (12). Finally, 
the in vivo finding of a cross-reaction in the immunity induced by adenovirus 7 
and 12 is confirmed. 
Materials and Methods 
M/ce.--Mice  of strains A/Sn, C3H/KL, A.SW/K.L, and A.CA/KL were used as well as 
A X CBA, A X C3H, A.BY X CBA, A.SW X C3H, and C3H X C57BL F1 hybrids. Their 
breeding and maintenance have been described (14). 
Aderan~us-Induced Tumors.--Five adeno 12 virus-induced  sarcomas were used, most of 
which have been described previously (4). Tumor A12.HA originated in a C3H female, tumors 
A12.HC and A12.HD originated in C3H males, and tumor A12.SBA  in an A X CBA F1 female 
mouse. Tumor A12.Ha2 originated in a hamster  inoculated with adenovirus type 12 when 
newborn. It was obtained from Dr. E. Norrby, The Swedish State Bacteriological Laboratory, 
Stockholm. 
Tumors Having the Polyoma Tumor Antigen.--Three tumor lines with  polyoma-specific 
transplantation antigens were used; namely one polyoma tumor clone SEWA-C10 of A.SW 
origin (15) and two clones, YAA-C1-C1-RC2 and YAA-C1-C3, of A/Sn origin. The latter 
two clones originated from a Moloney virus-induced leukemia, YAA, which had been repeat- 
edly infected with polyoma virus and as a consequence  had acquired the polyoma tumor trans- 
plantation antigen in addition to its original Moloney antigen (16). The YAA-C1-C1-RC2 
line had been cloned twice and the clones found to contain  both the polyoma and the Moloney- 
specific tumor antigens,  t Repeated tests showed that none of the polyoma antigenic lines con- 
tained or released detectable polyoma virus (16).1 The two lines of Moloney origin probably 
contained infective Moloney virus. 
Other Tumors.--Sarcoma RSC was induced in an A/Sn mouse by Schmidt-Ruppin-Rous 
virus (RSV--SR)  (17), and sarcoma TCHF was derived from C3H embryo cells grown in 
serial  tissue culture  until "spontaneous  transformation"  occurred, after which they were 
serially passaged in vivo.  ~ 
Virus.--Adenovirns types 12 (Huie), 7 (Gomen), and 5 were used for immunization  in titers 
of 0.3-7.3 X 106 PFU (adeno 12), 1.3-21 X 106 PFU (adeno 7), and 45-75 X 106 PFU (adeno 
5). The virus was given subcutaneously in five doses at weekly intervals. 
Polyoma virus was originally obtained from Dr. B. E. Eddy and was used for immunization 
in an amount of 128 HA units/animal. 
Sera.--Mice  were treated  with 2-24 doses of various tumor cells and/or viruses. Crude 
tumor cell suspensions were inoculated subcutaneously every 2nd wk into alternate flanks, 
and the animals were bled from the retroorbital plexus at various times (usually 1-2 wk) after 
the last dose of tumor. The detailed information for each serum is given in Table I. 
Lymphocytes.--Axillary, cervical, inguinal, and mesenteric lymph nodes were harvested 
from mice sensitized with a mixture 1  : 1 of crude tumor cell suspensions and complete Freund's 
1 Sjiigren,  H. O., and I. HellstrSm. Unpublished data. 
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TABLE I 
Do,  t,a on Antisvra Tested with the CI Techni~e 
Serum pool  No. 
Anti-adeno sera 
1625 
1686 
1718 
1787 
1820 
1840 
1788 
1854 
1767 
1826 
1829 
1709 
1711 
1715 
1793 
1796 
1798 
1699 
1695 
1693 
An~-H-2 svra 
1813 
1855 
Olher antisera 
1615 
1623 
1629 
1824 
1683 
1822 
17~ 
17~ 
1~1 
Serum donors 
A  X  CBA F1 
C3H 
A X  CBA Ft 
C3H X  C57L Ft 
ASW X  C3H F1 
A X  CBA Ft 
C3H 
tc 
A X  CBA F1 
~c 
A X  C3H Ft 
A X  C3H Ft 
L¢ 
~C 
A.SW 
A.CA 
A X  CBA F1 
~C 
A 
ASW X  C3H F1 
ABY X  CBA Ft 
A X  CBA Ft 
C3H 
~C 
Immunization  procedure 
A12.HA-HR 
ac 
A12.HC-HR 
A12.HD-HR 
A12.SBA 
~c 
A12.SBA-HR 
Adenovirus type 5 
"  "  12 
Adenovims type 5 
"  "  12 
Adenovirus type 12 
fC  c~  7 
Cg  g~  5 
YAA-CI-C1 RC2-HR 
A12.SBA 
SEWA-C10 -b PY virus 
~C 
YAA-C1-C3 
RSC 
tC 
TCI-IF-ttR 
No.  Of 
do~s 
12 
8 
9 
9 
15 
13 
8 
2 
18 
19 
12 
14 
19 
19 
12 
14 
24 
5 
5 
9 
Interval 
after last 
dose 
6 
45 
66 
13 
20 
6 
20 
15 
14 
43 
43 
73 
73 
73 
71 
71 
71 
2 
15 
2 
12 
6 
2 
7 
51 
12 
14 
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TABLE  II 
Plating  g~ciency of Alg.HC  Tumor  Cells after  Exposure  to Antisera  against Adenovirus- 
Induced and Control Tumors, Respectively* 
Sera 
C3H anti-TCHF-HR No. 
1769 (control) 
C3H anti-YAA-CI-C3 No. 
1813 (antipolyoma) 
C3H anti-A12.SBA No. 
1767 
C~H anti-AI2.HA-HR No. 
1787 
C3H antI-AI2.HD-HR No. 
1788 
Colonies/plate after incubation with serum dilution 
Experiment 1  Experiment 2 
1:2  1:4  1:8 
45-4-3 
17 ::E 1 
P  <  0.0015 
1:4 
20=1:: 2 
16~2 
P  <  0.01 
1:8 
43~2 
27-4-1 
P  <  0.01 
25 -4-3 
27-4-1 
14  -~- 3 
0.1  >  P  >  0.05 
11  :~:  1.5 
P  <  0.05 
7.7-4-1 
P  <  0.01 
24-4-  4 
26-t-2 
11-4-3 
P  <  0.05 
19"4-1 
P  >  0.05 
12.7 -4- 3 
0.1  >  P  >  0.05 
* The number of colonies formed after plating of 1250 eells/Petri dish. 
Significance of the difference  in colony number after incubation with the serum in question compared to 
control serum (according to the Student t test). 
TABLE  III 
Plating E~eiency of A12.HD  Tumor  Cells after Exposure to Antisera  against Adeno  Tumors 
and Adeno 12 Virus, Respectivdy* 
Sera 
C3H anti-TCHF-HR  No.  1831  (control) 
C3H anti-YAA-C1-C3 No.  1824 (anti- 
polyoma 
C3H anti--ndeno A12.SBA-HR No.  1829 
A  X  C3H F1 anti-adeno  12 virus No. 
1798 
Colonles/plate after incubation with serum dilution 
1:2 
264-2 
284-7 
144-4 
P  >  o.1~ 
64-2 
P  <  0.005 
1:4 
224-2 
23  4-3 
12  4-  0.7 
P  <  0.05 
17  4-3 
P>O.1 
1:8 
22 
274-3 
194-3 
P  >  0.05 
* The mean number of colonies formed after plating of  1250  ceils into each of three Petri 
dishes and the standard error of the mean. 
Significance of the difference in colony number after incubation  with the serum in ques- 
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TABLE IV 
Plating E~ciency of Alg.SBA  Tumor Cells after Exposure to A  )< CBA F1 Anbisora against 
Adeno Tumor A12.HA.* 
Experiment  Antiserum 
batch No. 
1718 
1686 
1625 
Serum dilution 
1:2 
1:4 
1:2 
1:4 
1:2 
1:2 
1:4 
1:2 
1:4 
1:2 
1:4 
1:2 
1:4 
Undiluted 
1:2 
1:4 
Undiluted 
1:2 
1:4 
1:8 
Undiluted 
1:2 
1:4 
Undiluted 
1:2 
1:4 
Colonies/plate after incubation with 
Control serum 
644-6 
674-1 
544-  1 
444-0 
32  4-3 
404-2 
41  4-3 
644-6 
674-  1 
544-  1 
444-0 
614-5 
52  4-4 
384-2 
504-  1 
504-2 
72  4-2 
704-3 
664-3 
614-7 
714-4-4 
67  4-5 
894-5 
274-5 
384-4-4 
394-3 
Antiserum 
404-*-3 
534-1 
41  4-6 
34+3 
194-4-  1 
204-4-6 
14+  7 
23  4-3 
1.3  4-  0.3 
45  +2 
274-*-2 
6-4-0.5 
12  -4-2 
34-0.3 
79.4-4 
68-4-1 
57  -4-2 
41-4-1 
61  -4-2 
56-4-  1 
44-1-  10 
17-4-2 
25  +2 
20  -4-3 
P~ 
<0.05 
<0.01 
0.1  >  P  >  0.05 
0.1  >  P  >  0.05 
<0.05 
<0.02 
<0.05 
<O.OOl 
<O.OOl 
<0.05 
<0.OO5 
<O.OOl 
<O.OOl 
<O.OOl 
>0.05 
>0.05 
0.1  >  P  >  0.05 
<0.05 
0.1>  P  >  0.05 
0.1>  P  >  0.05 
<0.02 
0,1  >  P  >  0.05 
<0.05 
<0.05 
* The number of colonies formed after plating of 500 ceUs/Petri dish. 
Significance of the difference in colony number after incubation with the serum in ques- 
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adjuvant. Information on the immunization procedure is given in a  footnote to Table VII. 
Lymphocyte suspensions were prepared by pressing the nodes through a  60-mesh stainless 
steel screen into Eagle's culture medium. 
The Colony Inhibition  (C1) Technique.--The  CI tests for detection of humoral antibody 
activity were performed as previously described (11,  12).  Trypglniwed cell suspensions were 
appropriately diluted in conditioned Eagle's medium containing 40% fetal calf serum. Volumes 
of 0.1 ml were added to tubes containing 0.1 ml antisera of different dilutions. The mixtures 
were incubated for 20 rain at 37°C, after which 0.8 ml of guinea pig complement, undiluted 
TABLE  V 
Plating E~ciency of A 12.HC Tumor Cells after Exposure to Mouse Antiscra against A denovirus 
Types 12, 7, and 5, gespe~tlvdy* 
Sera 
C3H anti-TCHF-HR No. 1769 
(control) 
A X  C3H F1 anti-adeno 12 virus 
No. 1798 
A  X  C3H F1 anti-adeno 7 virus No. 
1796 
A  X  C3H F1 anti-adeno 5 virus No. 
1793 
Colonies/plate after incubation with serum dilution 
Experiment 2  Experiment 3 
1:4  1:8  1:8 
25-4-3 
84-0.4 
P  <  0.01 
22  4-3 
P  >  0.05 
304-  1 
P  >  0.05 
244-4 
124-1 
P  <  0.05 
144-  1 
0.1  >  P  >  0.05 
304-2 
P  >.0.05 
244-2 
164-2 
P  <  0.05 
16-4-  1 
P  <  0.05 
28=/=0 
P  >  0.05 
* The number of colonies formed after plating of 1250 ceLls/Petri dish. 
See $ footnote to Table H. 
or diluted 1:2, was added. After another 60 rain of incubation the content of each tube was 
diluted with Eagle's medium containing 40% fetal calf serum and plated into 50-ram Falcon 
plastic Petri dishes in allquots of 4 ml. The dishes were incubated for 7 days at 37°C in a 5% 
COs in air atmosphere, stained with crystal violet, and the number of colonies counted. Usu- 
ally three paralld dishes were used for each serum dilution. The mean number 4- the standard 
error of the mean is given in the tables. The significance of the differences in the number of 
colonies obtained with the various sera was evaluated by the Student t test. 
The CI method was modified also to detect cell-bound immunity (13). Trypsinized tumor cell 
suspensions were added to Petri dishes and the cells allowed to attach to the surface of these 
during 12-24 hr, after which the culture medium was discarded and 0.3 ml of Wellcome phyto- 
hemagglutinin (PHA) diluted 1 : 15 was added, followed by 0.5 ml of a  suspension of lymph 
node cells (from axillary, inguinal, cervical, and mesenteric lymph nodes) in culture medium. 
After 45 rain 4 ml Eagle's culture medium with 15~0 fetal calf serum was added to each Petri 
dish. The dishes were incubated for 3-4 days and afterwards stained and counted as in the 
plating experiments described previously. 
RESULTS 
Induction  of Humoral  (CI-)  Antibodies  against Adeno 12 Mouse Sarcomas by 
Immunization  with Adeno 12 Mouse Tumors and with Adenovirus Types 12 and 7. INGEGERD  HELLSTROM  AND  HANS  O.  SJOGREN  1111 
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--Tables II-V and Fig. 1 illustrate the findings. It appears that colony numbers 
formed by each of three different adeno 12 mouse tumors (A12.HC, A12.HD, 
and A12.SBA) were markedly fewer, after exposure of the tumor ceils to anti- 
sera from syngeneic donors immunized against any of these tumors, than those 
of controls for which hyperimmune sera against sarcoma TCHF (of no known 
viral  origin)  were  used.  Antisera  directed  against  polyoma-,  RSV-SR-,  or 
Moloney-specific tumor antigens did not reduce colony numbers. Complement 
was needed in order to demonstrate colony inhibition with the specific antisera, 
TABLE  VI 
Plating  Efficiency of Alg.Ha2 Hamster  Tumor Cdls after Exposure to Various 
Mouse Anti-Adeno lg Mouse  Tumor Sera* 
Colonles/plate after incubation with serum  dilution 
Sera~  Experiment 2  Experiment 3 
1:2  1:4  1:2  1:4  1:8 
Anti-Rous (RSC) No. 
1822 (control) 
Anti-adeuo (A12.HA-HR) 
No,  1787 
314-4 
214-3 
P  >  0.1§ 
394-3 
184-1 
P  <  0.02 
1:8 
234-3 
114-2 
P  <  0.05 
14  4-  0.4 
44-1 
P  <  0.001 
15  4-0.5 
54-1 
P  <  0.01 
204-O 
54-1 
P  <  0.001 
Anfi-adeno (A12.HC-HR) 
No.  1820 
Anti-adeno (AI2.HD-HR) 
No.  1788 
Anti-adeno (A12.SBA) 
No.  1767 
9.5  4-  4.5 
P  <  0.05 
194-2 
0.1  >  P  >  0.05 
184-2 
P  <  0.01 
144-3 
P  <  0.01 
214-1 
P>0.1 
24  4-  0.5 
P>O.I 
44-0,5 
P  <  0.001 
24-0.5 
P  <  0.001 
3-4-0 
P  <  0.001 
24-0.5 
P  <  0.001 
54-I 
P  <  0.00l 
1.3  4-  0.9 
P  <  0.001 
* The number of colonies formed after plating of 500-1000 cells. 
All sera were obtained from mice treated with living  mouse tumor cells, either untreated or irradiated with 
8000 R  immediately before inoculation. 
§ See  ~ footnote to Table II. 
as in previous experiments (11,  12). Reduction in colony numbers with specific 
antisera was most often in the range of 40-70 %  and it was highly significant 
according to t tests (see tables). 
The data presented in Table IV show that the reduction was reproducible in 
repeated experiments with the same sera.  In one experiment (serum  1625 in 
Experiment  7,  Table IV)  no  activity was  demonstrated in undiluted or  1:2 
diluted  serum,  although  these  dilutions  were  positive  in  other  experiments. 
Since serum dilutions 1:4 and 1:8 in the same experiment gave colony inhibition, 
the negative findings with the more concentrated antiserum might be due to 
an anticomplementary effect. Also in other experiments with the same serum it 
was more effective in higher dilutions. As a rule, the activity of various sera was INGECERD  HELLSTROM  AND  HANS  O.  SJOGREN  1113 
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maintained after dilution up to at least 1:8. However, determinations of serum 
titers were not attempted. 
Sera from donors which had received four to five doses of adenovirus types 
5, 7, or 12 were also tested against mouse adeno 12 tumors. As shown in Table V 
and Fig.  1 sera from adeno 12- and adeno 7-infected donors significantly re- 
duced the plating efficiency of adeno 12 tumor cells, while sera from adeno 5- 
TABLE  VII 
Effect of Immune  Lymph  Node Cells on  Plating  E~cien~y of  Alg.SBA  Tumor Cells* 
Experi- 
ment 
No. ot 
lymph 
cells 
5  X  lO  s 
106 
l0  T 
5  X  lO  s 
107 
5  X  106 
106 
107 
5  X  106 
106 
Control 
syngeneic 
lymph node 
cclls~ 
584-4 
55  4-  0.3 
1094-3 
109  4-  4.5 
37.5  4-  1.5 
414-5 
42  4-4 
No. of colonies formed after exposure to 
Antitumor 
syngeneic 
lymph node 
cellst 
384-6 
47  4-2 
78  4-4 
954-  1 
>0.1 
<0.02 
<0.05 
0.1  >  P  >  0.05 
<0.05 
>0.1 
>0.1 
<0.02 
0.1  >  P  >  0.05 
>0.1 
Anti-H-2 
allogeneic 
lymph node 
ce11~$ 
264-2 
384-  2 
564-  1 
74  4-4 
244-0 
474-2 
394-  2 
234-2 
404-1 
394-  1 
54  4-  2 
544-2 
704-8 
264-4 
414-4 
60-4-4 
344-  2 
49  4-9 
664-2 
<0.02 
<0.01 
<0.01 
<0.05 
<0.01 
>0.1 
>0.1 
<0.01 
>0.I 
>0.i 
* The number of colonies formed after plating of 2000 cells. 
:~ Anticontrol lymph node cells were obtained from A X  CBA F~ mice immunized with 
SH2-HR tumor (Experiments  1 and 2)  or with  TCHF-HR cells (Experiments 3 and 4). 
Antitumor lymph node cells derived from A X  CBA Ft mice immunized with A12.HD-HR 
(Experiments 1, 3, and 4)  and A12.HC (Experiment 2). Anti-H-2 lymph node cells were 
taken from A.CA mice immunized against A12.SBA tumor.  Cells were isolated 2 wk after 
one single pretreatment in Experiments 1 and 2; 1 day and 2 wk  after two  doses in Ex- 
periments 3 and 4, respectively. 
infected donors were  inactive, except  in one case  (Experiment 3  in Fig.  1). 
Several sera from virus-infected mice were tested and found to contain rela- 
tively high titers of antiviral HI and CF antibodies. No antiviral activity was 
found in the serum of donors immunized with adeno 12 mouse tumor cells. 
Demonstration  of Cross-Reactivity  between  Adeno  12  Tumors  of Mouse  and 
Hamster by the CI Technique.--As shown in Table VI and Fig. 2, sera from mice 
immunized against irradiated syngeneic or untreated allogeneic adeno 12 mouse 
tumor cells reduced  the number of colonies formed by the adeno 12-induced INGEGERD HELLSTROM AND HANS O. SJOGREN  1115 
hamster tumor line. As controls, mouse sera against nonviral tumors and against 
polyoma and Rous tumors were used. Since the positive anti-adeno 12  tumor 
sera were not  active in  CI  tests  against  BHK  hamster  cells  or  BHK  cells 
transformed by polyoma or RSV-SR viruses, the findings indicate that mouse 
and  hamster tumors of adeno 12 origin share tumor-specific transplantation 
antigens. 
In  Vitro Demonstration  of Cell-Bound  Immunity  against  H-2  and  Tur,  wr- 
Specific  Antigens  of Adeno  12  Tumor Cd/s.--Three different types of lymph 
node cells were added to plated A12.SBA tumor cells (of A X  CBA FI origin), 
namely lymphocytes from syngeneic donors immunized against either of two 
nonadeno tumors  (for the controls), cells from allogeneic donors immunized 
against the H-2 antigens of the target cells,  and syngeneic cells from donors 
sensitized against the specific antigens of other adeno 12-induced tumors. 
As shown in Table VII, lymphocytes sensitized against either the H-2 anti- 
gens or the specific tumor antigens of the A12.SBA cells significantly reduced 
colony numbers if added in a  number of l0  T cells/dish; 10  6 cells gave a very 
weak reduction or no reduction at all, and 5 X  10  6 cells gave an intermediary 
reduction. Recent findings (unpublished) show that the addition of PHA is not 
a prerequisite for detecting inhibition with the sensitized lymphocytes. 
DISCUSSION 
The present findings demonstrate that  adeno  12  mouse sarcomas share  a 
specific antigen and that at least part of this antigen is present also in adeno 12- 
induced hamster tumor cells. Serum of adeno 7-infected mice was active against 
adeno 12 target cells, which may be explained by postulating a cross-reaction be- 
tween (tumor) antigens induced by adenovirus types 12 and 7 in the infected mice. 
The demonstrated specific antigenicity of adenovirus tumor cells is for several 
reasons considered to be identical with their previously reported specific trans- 
plantation antigenicity (4, 5). First, the CI technique is analogous to "short time 
cytotoxic tests" (18),  which demonstrate cell surface antigens, the concentra- 
tion of which determines the cellular sensitivity to  humoral antibodies and 
complement (9,  10); a similar surface localization of the transplantation tumor 
antigen has been postulated to account for recognition of the antigenic tumor 
cells by sensitized lymphocytes  in vivo (19). Second, the demonstration that the 
CI technique also reveals cell killing after contact with immune lymphoid cells 
in the absence of complement brings the in vitro findings and the in vivo find- 
ings considerably closer  together and suggests that the same surface antigens 
react under both conditions. Finally, the identity of the antigens detected by the 
CI test and the isograft immunity test is supported by the finding of colony 
inhibition with adeno 12  tumor cells exposed to serum from adeno 7-infected 
animals, since  this parallels the isograft immunity demonstration in the same 1116  DEMONSTRATION  OF  ADENO  12  TRANSPLANTATION  ANTIGENS 
animals to adeno  12 tumor cells.  On the other hand,  complement-fixing (CF) 
antigens of adeno 7 and adeno 12 tumors do not cross-react. This indicates that 
the CI and CF antigens are different. 
The cross-reactivity between adeno 12 tumors of mouse and hamster origin 
is analogous to the previously reported cross-reaction between polyoma tumors 
of mice and polyoma transformed BHK hamster cells (12). Recently, evidence 
was obtained also of common antigens in RSV-SR sarcomas of mouse, hamster, 
and chicken2 These data support  the  concept that  the tumor-specific trans- 
plantation  antigens  are  coded for by the  viral genome,  which  consequently 
must be maintained in tumor cells, even if they do not release infectious virus 
or contain detectable virion antigens (6, 20). Direct evidence for the presence of 
at least some parts of the adenovirus DNA in hamster tumor cells has been 
recently reported by Fujinaga and Green using a virus DNA-tumor cell RNA 
hybridization technique (21). In these experiments there was no evidence of a 
homology between adeno  7 DNA  and  adeno  12  tumor RNA.  However, this 
does not exclude the presence of a  common viral gene in adenovirus types 7 
and  12  coding for the  common transplantation  antigen as  suggested  by the 
present results. 
The successful in vitro demonstration of both humoral and cell-bound immu- 
nity directed against the adeno 12-specific transplantation antigens appears to 
provide tools for a closer study of the immune status of the primary tumor hosts 
before and after a visible tumor has developed. It is hoped that this will help 
to clarify the important question of the immunological events associated with 
the outgrowth of a primary antigenic tumor. 
SIYM~AR¥ 
A colony inhibition (CI) technique was used to demonstrate in vitro tumor- 
specific antigenicity common for neoplasms induced by the adenovirus type 12. 
Immunization of mice against syngeneic mouse adeno  12 tumor cells evoked 
immtmity demonstrable against other adeno 12 neoplasms of mice and of ham- 
ster as well.  The immunity was detected as antibody activity in the sera of 
specifically immunized mice and as a similar activity of the lymph node cells of 
these animals.  The finding in transplantation experiments that infection with 
adenovirus types 12 and 7 induces an isograft immunity against adeno 12 tu- 
mors was confirmed by CI tests on the sera of virus-infected mice. The proba- 
ble identity of the antigen detected by the CI technique and the tumor-specific 
transplantation antigen is discussed. 
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